Lista de obras -

A prospective, multicentre study in acute noncirrhotic, nonmalignant portal vein thrombosis: comparison of medical and interventional treatment

artículo científico publicado en 2020

Characterization of pre-existing and induced SARS-CoV-2-specific CD8+ T cells

artículo científico publicado en 2020

Comparison of local tumor control in patients with HCC treated with SBRT or TACE: a propensity score analysis

scientific article published on 09 August 2018

Editorial: acute non-cirrhotic and non-malignant portal vein thrombosis--who should be candidates for interventional treatment? Authors' reply

scientific article published on 01 August 2020

Editorial: is proton pump inhibitor use associated with worse outcomes in patients with liver abscesses? Authors' reply

artículo científico publicado en 2018

Follicular T Helper Cell Signatures in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis

artículo científico publicado en 2018

GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis

scientific article published on 08 November 2019

Improved survival prediction and comparison of prognostic models for patients with hepatocellular carcinoma treated with sorafenib

artículo científico publicado en 2019

Over-the-scope clips are cost-effective in recurrent peptic ulcer bleeding

scientific article published on 25 September 2019

Prediction of Survival Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma: A Response-Based Approach

artículo científico publicado en 2019

Survival benefit of transarterial chemoembolization in patients with metastatic hepatocellular carcinoma: a single center experience.

artículo científico publicado en 2017

Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion

artículo científico publicado en 2017

Treatment with proton pump inhibitors increases the risk for development of hepatic encephalopathy after implantation of transjugular intrahepatic portosystemic shunt (TIPS)

scientific article published on 15 August 2018

Treatment with proton pump inhibitors increases the risk of secondary infections and ARDS in hospitalized patients with COVID-19: coincidence or underestimated risk factor?

artículo científico publicado en 2020

Treatment with proton pump inhibitors is associated with increased mortality in patients with pyogenic liver abscess.

artículo científico publicado en 2018

Unusual endoscopic treatment of recurrent cough and pneumonia

artículo científico publicado en 2018

Lista de obras de

A prospective, multicentre study in acute noncirrhotic, nonmalignant portal vein thrombosis: comparison of medical and interventional treatment

Characterization of pre-existing and induced SARS-CoV-2-specific CD8+ T cells

Comparison of local tumor control in patients with HCC treated with SBRT or TACE: a propensity score analysis

Editorial: acute non-cirrhotic and non-malignant portal vein thrombosis--who should be candidates for interventional treatment? Authors' reply

Editorial: is proton pump inhibitor use associated with worse outcomes in patients with liver abscesses? Authors' reply

Follicular T Helper Cell Signatures in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis

GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis

Improved survival prediction and comparison of prognostic models for patients with hepatocellular carcinoma treated with sorafenib

Over-the-scope clips are cost-effective in recurrent peptic ulcer bleeding

Prediction of Survival Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma: A Response-Based Approach

Survival benefit of transarterial chemoembolization in patients with metastatic hepatocellular carcinoma: a single center experience.

Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion

Treatment with proton pump inhibitors increases the risk for development of hepatic encephalopathy after implantation of transjugular intrahepatic portosystemic shunt (TIPS)

Treatment with proton pump inhibitors increases the risk of secondary infections and ARDS in hospitalized patients with COVID-19: coincidence or underestimated risk factor?

Treatment with proton pump inhibitors is associated with increased mortality in patients with pyogenic liver abscess.

Unusual endoscopic treatment of recurrent cough and pneumonia